Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trifecta-Kidney cfDNA-MMDx Study: Comparing the DD-cfDNA Test to MMDx Microarray Test, Central HLA Antibody Test, and Histology.

NCT04239703 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT04239703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04239703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trifecta-Kidney cfDNA-MMDx Study: Comparing the DD-cfDNA Test to MMDx Microarray Test, Central HLA Antibody Test, and Histology.
Lead sponsor
University of Alberta
Phase
Observational
Overall status
Recruiting
Start date
December 1, 2019
Completion date
December 31, 2029
Enrollment
300 (estimated)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant rejection